GPCR/G protein
All GPCRs share a common seven trans-membrane structure. GPCRs are associated with heterotrimeric G-proteins which are GTP-binding proteins made of alpha, beta, and gamma subunits. When a ligand binds to GPCR, it activates the attached G-protein, the GDP is replaced with GTP. The activated G-protein then dissociates into an alpha and a beta-gamma complex which activates downstream signaling pathways. These intracellular signaling pathways include cAMP/PKA, calcium/NFAT, phospholipase C, protein tyrosine kinases, MAP kinases, PI-3-kinase, nitric oxide/cGMP, Rho, and JAK/STAT.
GPCRs are one of the most important therapeutic targets for various diseases, over 30% of all modern medicinal drugs target this family. Aberrant GPCR functions are involved in pathological conditions such as neurological, immunological and hormonal disorders. A large number of GPCRs have been identified, but whose ligands are not known, are classified as orphan receptors.
- B5656 PBP 10Summary: formyl peptide receptor 2 (FPR2) antagonist
- B5667 TT 232Summary: sst1/sst4 somatostatin receptors agonist
- B5683 RFRP 3 (human)Summary: NPFF1 receptor agonist
- B5703 FSLLRY-NH2 TFASummary: PAR2 peptide antagonist
- B5768 PG 106Summary: hMC3 receptor antagonist
- B5803 ANQ 11125Summary: Motilin receptor antagonist,selective
- B5807 PG 931Summary: melanocortin 4 (MC4) receptor agonist
- B5808 OXA (17-33)Summary: orexin OX1 receptor agonist
- B5810 CTCE 9908Summary: CXCR4 antagonist
- B5813 DMNPE-caged ATP diammonium saltSummary: DMNPE-caged ATP